NEURON BPh is a Spanish biotech Company, whose main objective is to discover and evaluate pharmaceutical and nutraceutical products to prevent and treat neurodegenerative disease, especially Alzheimer’s Disease.

NEURON BPh also works on the development of bioprocesses for pharmaceutical, chemical, agro-food and bio-energy applications.

As a first priority, NEURON BPh will continue to develop its proprietary lead molecules to clinical phase I/IIa whereafter the company is interested in out-license the projects.

The company also aims to attract a co-development partner for its Nutraceutical lead molecules. At this point, NEURON BPh plans to enter both the European as well as the US market.

The company plans to expand its pipeline of potential lead molecules utilizing in-licensing and in-house drug re-profiling strategies.